- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01606553
Inspiratory Muscle Training in Patients With Chronic Heart Failure (INCA)
February 15, 2016 updated by: Esther Marco Navarro, Parc de Salut Mar
The INCA Study: Inspiratory Muscle Training in Patients With Chronic Heart Failure
The purpose of this study is to determine whether a high intensity short duration inspiratory muscle training is feasible, secure and effective to improve respiratory muscle function (strength and resistance), health-related quality of life, and to assess potential correlations with health resources utilization.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Patients with chronic heart failure (CHF) often refer exercise intolerance, marked fatigue and dyspnea at low exercise intensities.
This characteristic feature might be generated by respiratory and skeletal muscle dysfunction, and it´s has been described as a comorbid status, reflecting the systemic impact of heart failure.
Despite the availability of effective pharmacologic treatments, patients with CHF continue to experience progressively worsening symptoms, frequent hospital admission and premature death.
Reduced physical functioning, role limitation, and lack of energy may interfere with daily activities as the condition worsens and thereby severely reduce the quality of life in CHF patients.
The ACCF/AHA Guidelines for the diagnosis and management of heart failure recommend exercise training as an adjunctive approach to improve clinical status in stable adult patients with current or prior symptoms of heart failure and reduced left ventricular ejection fraction.
A wide variety of studies have focussed on respiratory muscles abnormalities in CHF patients.
Reduced strength and endurance of respiratory muscles are currently recognized as additional factors implicated in the limited exercise response and quality of life, as well as in a poor prognosis.
Additionally, inspiratory muscle training (IMT) has shown to result in improvements on inspiratory strength, functional capacity, ventilatory response to exercise, recovery oxygen uptake kinetics, and quality of life of CHF patients with respiratory muscle weakness.
The optimal training scheme remains still to be defined.
Most of clinical trials have demonstrated the effectiveness of a low-intensity IMT (maximum 38 cmH2O), but there is little information of the training effects when using higher training loads.
Our research group has demonstrated that a short-time high-intensity respiratory training in patients with chronic obstructive pulmonary disease afford to reach good functional results in a shorter time, which affords to make more efficient in terms of time the rehabilitation program and to reach to more patients.
Study Type
Interventional
Enrollment (Actual)
22
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Barcelona, Spain, 08003
- Hospital del Mar
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age over 18 years;
- chronic heart failure (CHF) of any etiology;
- clinically stable condition, with no worsening of heart failure or change in cardiac medication in the previous 3 months and during the study; and
- ability to understand and accept the trial procedures and to sign an informed consent form in accordance with national legislation.
Exclusion Criteria:
- previous history of any chronic respiratory disease;
not to have performed any kind of general or respiratory training in the previous 3 months.
- Prior to randomization, all patients' clinical assessment and echocardiographic measurements were done by a cardiologist and all patients underwent pulmonary function tests.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: High-intensity IMT
High intensity short duration respiratory muscle training (IMT) using a dual-vave prototype
|
High intensity short duration respiratory muscle training with a valve prototype
Other Names:
|
Active Comparator: Sham High-intensity IMT
High intensity short duration respiratory muscle training (IMT) using a sham dual-vave prototype
|
High intensity short duration respiratory muscle training using a sham valve prototype
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in respiratory muscle function strength
Time Frame: Baseline to 4 weeks
|
Transducer measuring maximal inspiratory and expiratory pressures
|
Baseline to 4 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in health-related quality of life
Time Frame: Baseline to 4 weeks
|
Minnesotta Living wih Heart Failure Questionnaire and Short Form 36
|
Baseline to 4 weeks
|
Adverse effects from training
Time Frame: Baseline to week 4
|
Adverse events collection by investigator
|
Baseline to week 4
|
Health care utilization
Time Frame: Baseline to one year
|
Hospital admissions and emergency room visits
|
Baseline to one year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Ferran Escalada, Md, PhD, Parc de Salut Mar
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
January 1, 2012
Study Completion (Actual)
June 1, 2012
Study Registration Dates
First Submitted
May 21, 2012
First Submitted That Met QC Criteria
May 23, 2012
First Posted (Estimate)
May 25, 2012
Study Record Updates
Last Update Posted (Estimate)
February 17, 2016
Last Update Submitted That Met QC Criteria
February 15, 2016
Last Verified
February 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INCA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Heart Failure
-
Maastricht University Medical CenterUniversity College Dublin; RWTH Aachen University; Queen's University, BelfastCompletedChronic Heart FailureNetherlands, Germany, Ireland, United Kingdom
-
Wuerzburg University HospitalRecruitingHeart Failure | Chronic Heart Failure | Chronic Heart DiseaseGermany
-
Jordan Cardio Vascular Research GroupRecruitingHeart Failure | Chronic Heart Failure | Acute Heart FailureJordan
-
Lithuanian University of Health SciencesCompletedHeart Failure | Chronic Heart Failure | Congestive Heart Failure | Right Ventricular FailureLithuania
-
Zensun Sci. & Tech. Co., Ltd.RecruitingChronic Heart FailureChina
-
University Hospital, Clermont-FerrandHospices Civils de Lyon; University Hospital, Grenoble; Hôpital de la Croix-Rousse and other collaboratorsRecruitingHeart Failure | Chronic Heart Failure | Acute Heart FailureFrance
-
University of Roma La SapienzaUnknownChronic Heart Failure | Decompensated Heart Failure | Morality
-
University Medicine GreifswaldDeutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)RecruitingChronic Heart FailureGermany
-
University Hospital, Gentofte, CopenhagenUnknownChronic Heart Failure | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure NYHA Class IVDenmark
-
AquaPass Medical Ltd.CompletedChronic Heart FailureIsrael
Clinical Trials on High-intensity IMT
-
Hospital Universitari Vall d'Hebron Research InstituteNot yet recruiting
-
Universidade Federal do Rio Grande do NorteCompleted
-
Texas Woman's UniversityTexas Health ResourcesCompletedHeart Failure NYHA Class II | Heart Failure NYHA Class IIIUnited States
-
Federal University of BahiaUnknown
-
Universidade Federal de Santa MariaCompletedComplications Due to Coronary Artery Bypass GraftBrazil
-
Parc de Salut MarCompleted
-
Chulalongkorn UniversityCompletedObstructive Sleep ApneaThailand
-
Istanbul UniversityNot yet recruiting
-
Queen's UniversityRecruiting
-
University of MichiganCompletedGlucose IntoleranceUnited States